← FDA Drug Approvals (Drugs@FDA)

NAPROXEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 1998-06-30

Drug application

FDA Application #

ANDA075227

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAPROXEN

Generic name

Naproxen

Active ingredients

NAPROXEN

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA

First approval

1998-06-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown